Please assess the completion status of the following clinical trial:

Trial Title: Single Dose Escalation Study of ONO-9054 in Healthy Volunteers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 7.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy male or female subjects, aged 18-64 inclusive~* Body mass index (BMI) of 19-35 kg/m2 (inclusive)~* IOP measurement oculus uterque (OU, both eyes) \< 21 mm Hg (inclusive) at screening and Day -1~* Best corrected visual acuity (BCVA) 20/30 or better (Snellen Equivalent) at both the screening visit and Day -1~Exclusion Criteria:~* Any history of severe ocular trauma in either eye at any time~* Any history of previous intraocular or ocular laser surgery within the past 3 months or any refractive surgery procedure within the past 6 months of the screening visit in either eye~* Current or chronic history of ocular infection within the past 3 months of screening visit in either eye OR ongoing or recurrent ocular inflammation in either eye~* At the ophthalmic investigator's discretion, any subjects who have a history of any significant ocular conditions in either eye that would contraindicate the use of the study medication, or that might affect the study conduct, or the interpretation of the study results~* Use of any non-diagnostic topical ophthalmic solutions except for sponsor-recommended tear substitutes from admission to the study unit through the duration of the study~* History of clinically significant drug or food allergy, positive HIV, hepatitis B or C at screening

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 64 Years
- Healthy Volunteers: t

Study Arms:
- Eye drops 0.3 µg/mL (Type: EXPERIMENTAL): None
- Eye drops 1 µg/mL (Type: EXPERIMENTAL): None
- Eye drops 3 µg/mL (Type: EXPERIMENTAL): None
- Eye drops 10 µg/mL (Type: EXPERIMENTAL): None
- Eye drops 20 µg/mL (Type: EXPERIMENTAL): None
- Eye drops 30 µg/mL (Type: EXPERIMENTAL): None
- Eye drops placebo (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).